MedTrace Logo

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

NCT04892706 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 686

Last updated 2025-10-30

Study results available
· View outcomes & findings →

Summary

The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo® Forte and IDP-126 Vehicle Gel.

Conditions

  • Acne Vulgaris

Interventions

DRUG

IDP-126 Gel

Gel applied to face once daily in the evening.

DRUG

IDP-126 Vehicle Gel

Gel applied to face once daily in the evening.

DRUG

Epiduo® Forte Gel

Gel applied to face once daily in the evening.

Sponsors & Collaborators

  • Bausch Health Americas, Inc.

    lead INDUSTRY

Principal Investigators

  • Varsha Bhatt · Bausch Health Americas, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-11
Primary Completion
2022-09-28
Completion
2022-09-28
FDA Drug
Yes

Countries

  • United States
  • Belgium
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04892706 on ClinicalTrials.gov